Appellate

Win at the Federal Circuit with Sterne Kessler’s appellate litigation team, led by former U.S. Supreme Court, Federal Circuit, and other appellate clerks.

Combining a long track record and experience base at the Federal Circuit and with its leadership at the U.S. Patent and Trademark Office's Patent Trial and Appeal Board (PTAB), Sterne Kessler has become a "go-to" firm for Federal Circuit appeals involving IPRs/CBMs/PGRs under the America Invents Act (AIA). Sterne Kessler’s long-standing appellate practice has served the intellectual property litigation needs of its clients for most of the firm's 45-year history. Its practitioners have been involved in many of the seminal patent law cases to reach the Court of Appeals for the Federal Circuit and the U.S. Supreme Court over the past 30+ years. That includes direct involvement in cases such as Alice Corp. v. CLS Bank, KSR v. Teleflex and Phillips v. AWH Corp. as well as serving as lead counsel in In re Beauregard and In re Wands. With a long track record and experience base at the Federal Circuit, work in this venue has grown considerably in recent years. Similar to the firm's rise in PTAB Litigation, Sterne Kessler has become a leader in Federal Circuit appeals involving IPRs/CBMs under the America Invents Act (AIA). With the recent explosion of Federal Circuit appeals from those proceedings, Sterne Kessler has emerged as a "go-to" firm for appeals from the Patent Trial and Appeal Board (PTAB). Firm attorneys have been lead counsel most recently for clients such as Google, Immunogen, Global Tel*Link, Spectrum Brands, Medtronic and Level 3 Communications, as well as for Ricoh, Xerox and Lexmark in a joint case against the well-known patent assertion entity MPHJ. Those cases cover a wide range of technologies and complex legal issues. Sterne Kessler has been co-counsel on cases before the Supreme Court, including the seminal Alice case. In addition to playing a direct role in Supreme Court cases, Sterne Kessler has worked on behalf of numerous clients and industry groups to prepare amicus briefs in relation to intellectual property cases before the Supreme Court.

Related Resources

Speaking Engagement

June 20, 2024 11:30 AM - 12:30 PM PST

15th Summit on Biosimilars & Innovator Biologics

Firm Announcements

April 24, 2024

Sterne Kessler Secures Victory on Behalf of Client Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox

In the News

April 23, 2024

US Supreme Court Denies Vanda’s Bid to Revive Sleep Drug Patents

Life Sciences Intellectual Property Review